Paris, France and Camberley, UK – 5 August 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), a leading international specialist in clinical diagnostics, announces that it will hold an investor meeting on Wednesday, 18 August 2021, at 13:00 BST / 14:00 CEST. http://novacyt.com/wp-content/uploads/2021/08/Novacyt-Notice-of-Investor-meeting-.pdf
Visit PageYear: 2021
David Allmond est nommé Directeur Général suite à la décision de Graham Mullis de prendre sa retraite
Paris, France et Camberley, Royaume-Uni – 29 juillet 2021 – Novacyt (EURONEXT GROWTH : ALNOV ; AIM : NCYT), spécialiste international du diagnostic clinique, annonce la nomination de David Allmond en tant que Directeur général et membre du Conseil d’administration à compter du 18 octobre 2021. À cette date, Graham Mullis, ayant informé le conseil
Visit PageDavid Allmond announced as CEO following decision by Graham Mullis to retire
Paris, France and Camberley, UK – 29 July 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), a leading international specialist in clinical diagnostics, announces the appointment of David Allmond as CEO and a member of the Board of Directors effective from 18 October 2021. At that time Graham Mullis, having informed the Board that he
Visit Page